After approval of gadopentetate dimeglumine by the US Food and Drug Administration (FDA) in 1988, the use of GBCAs has multiplied, aiding lesion depiction and therapeutic guidance in over 500 million ...

These products were expected to be unavailable starting in January. Gadobenate Dimeglumine Injection: Bracco Diagnostics reported a shortage of several presentations of this contrast agent.

Endolymphatic hydrops (EH) is considered the histological hallmark of Meniere's disease. Visualization of EH has been achieved by special sequences of inner ear magnetic resonance imaging (MRI) with a ...